EXACT Total Current Liabilities from 2010 to 2025
| EXAS Stock | USD 64.64 0.21 0.32% |
Total Current Liabilities | First Reported 2000-06-30 | Previous Quarter 502.5 M | Current Value 521.9 M | Quarterly Volatility 224.8 M |
Check EXACT Sciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among EXACT Sciences' main balance sheet or income statement drivers, such as Interest Expense of 33.6 M, Other Operating Expenses of 3.1 B or Research Development of 452.8 M, as well as many indicators such as Price To Sales Ratio of 3.56, Dividend Yield of 0.0 or PTB Ratio of 4.49. EXACT financial statements analysis is a perfect complement when working with EXACT Sciences Valuation or Volatility modules.
EXACT | Total Current Liabilities | Build AI portfolio with EXACT Stock |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for EXACT Stock Analysis
When running EXACT Sciences' price analysis, check to measure EXACT Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EXACT Sciences is operating at the current time. Most of EXACT Sciences' value examination focuses on studying past and present price action to predict the probability of EXACT Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move EXACT Sciences' price. Additionally, you may evaluate how the addition of EXACT Sciences to your portfolios can decrease your overall portfolio volatility.